LIU, HUAILU – Trademark Portfolio

Entity Type: 01

LIU, HUAILU holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include OARKIVE. The owner is based in ZUNYI CITY,GUIZHOU PROVINCE.

DISTRICTGONGQING AVENUE,LONGKENG TOWN

204,UNIT 1,BUILDING 6,HUANFANG 2 GONGQING AVENUE,LONGKENG TOWN

ZUNYI CITY,GUIZHOU PROVINCE 563000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OARKIVE
OARKIVE
Registered 2024
OARKIVE
OARKIVE
Registered 2017

Trademark Classifications

LIU, HUAILU's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does LIU, HUAILU have?

LIU, HUAILU has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does LIU, HUAILU file in?

LIU, HUAILU files trademarks across 2 Nice Classification classes. The most active classes are Class 16 (Paper Goods), Class 5 (Pharmaceuticals). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.

What are LIU, HUAILU's most well-known trademarks?

LIU, HUAILU's registered trademark portfolio includes well-known marks such as OARKIVE. These are among 2 currently registered trademarks in the portfolio.

What is LIU, HUAILU's trademark registration success rate?

LIU, HUAILU has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.